Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases	autoimmune disease, immune system disorder	Recruiting	Phase 1 / Phase 2	2026-03-10		NCT06688799

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing GoBroad Hospital	42

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing GoBroad Hospital	Beijing	China	1

Clinical trials